Cite
Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease.
MLA
Liu, Zhengxia, et al. “Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease.” PLoS ONE, vol. 10, no. 6, June 2015, pp. 1–11. EBSCOhost, https://doi.org/10.1371/journal.pone.0131086.
APA
Liu, Z., Zhang, M., Wu, J., Zhou, P., Liu, Y., Wu, Y., Yang, Y., & Lu, X. (2015). Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease. PLoS ONE, 10(6), 1–11. https://doi.org/10.1371/journal.pone.0131086
Chicago
Liu, Zhengxia, Mengyao Zhang, Jin Wu, Ping Zhou, Ying Liu, Yucheng Wu, Yujiao Yang, and Xiang Lu. 2015. “Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease.” PLoS ONE 10 (6): 1–11. doi:10.1371/journal.pone.0131086.